We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Prebiotic Effect on Metabolites in Crohn's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01487759
Recruitment Status : Completed
First Posted : December 7, 2011
Last Update Posted : December 12, 2011
Information provided by (Responsible Party):

December 6, 2011
December 7, 2011
December 12, 2011
March 2008
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01487759 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Prebiotic Effect on Metabolites in Crohn's Disease
Metabolite Profiling of the Impact of Oligofructose Enriched Inulin in Crohn's Disease Patients
The purpose of this study is to investigate the influence of the prebiotic oligofructose enriched inulin on the metabolite pattern in Crohn's disease patients.
Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Basic Science
Crohn Disease
  • Dietary Supplement: Oligofructose enriched inulin
  • Dietary Supplement: Maltodextrin
  • Active Comparator: Prebiotic
    Intervention: Dietary Supplement: Oligofructose enriched inulin
  • Placebo Comparator: Placebo
    Intervention: Dietary Supplement: Maltodextrin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
July 2009
Not Provided

Inclusion Criteria:

  • crohn's disease

Exclusion Criteria:

  • severe crohn's disease (harvey bradshaw index >12)
  • pregnancy
  • history of colectomy
  • use of antibiotics 4-wks before start of the study
  • use of sulfapyridine
  • use of commercially available prebiotics and probiotics
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Kristin Verbeke, Katholieke Universiteit Leuven
Katholieke Universiteit Leuven
Not Provided
Not Provided
Katholieke Universiteit Leuven
December 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP